GC Aesthetics enhanced with $60m investment

The transaction saw new investor OrbiMed contribute $40m, while the remaining $20m came from existing investors Montreux Equity Partners and Oyster Capital.

The funding will be used to support the company's continued international expansion, as well as new product development and launches.

New York-based OrbiMed is a healthcare-focused investor, which targets businesses globally. Montreux is a growth capital investor with a focus on health products, technologies and services. Oyster Capital is based in Ireland and invests in technology, software, waste and energy businesses.

Company
Based in Dublin, GC Aesthetics manufactures products used for plastic surgery. Its key brands are UK-based Nagor and France-based Eurosilicone.

Founded in 2007, the company sells its breast implants in 90 countries and its product range includes 600 types of implants. The products are manufactured at sites across the UK and France.

People
Ayse Kocak is the CEO of GC Aesthetics. Daniel Turner is managing director of Montreux and also serves as GC Aesthetics' chairman.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Healthcare
• Ireland